Search for Clinical Trial Results
Edema - 449 Studies Found
Status | Study |
Recruiting |
Study Name: Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients Condition: Hereditary Angioedema Date: 2011-05-19 Interventions: Drug: rhC1INH Patients up to 84 kg will receive one i.v. injection of Ruconest at a dose of 50 U/kg. The |
Terminated |
Study Name: Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated Angioedema Condition: ACE Inhibitor-associated Angioedema Date: 2011-12-14 Interventions:
|
Completed |
Study Name: Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks Condition: Hereditary Angioedema Date: 2012-06-29 Interventions: Biological: CINRYZE with rHuPH20 Other Names:
|
Completed |
Study Name: A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema Condition: Hereditary Angioedema Types I and II Date: 2013-07-29 Interventions:
|
Completed |
Study Name: Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE) Condition: Hereditary Angioedema Date: 2007-04-04 Interventions: Drug: ecallantide solution for SC injection, one 30 mg dose per HAE attack |
Completed |
Study Name: A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3) Condition: Hereditary Angioedema Date: 2009-06-02 Interventions:
|
Completed |
Study Name: Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE) Condition: Hereditary Angioedema Date: 2007-07-12 Interventions:
|
Withdrawn |
Study Name: Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema Condition: Hereditary Angioedema Date: 2010-12-02 Interventions: Biological: ecallantide 10 - 30mg subcutaneous injection. |
Completed |
Study Name: CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12 Condition: Hereditary Angioedema Date: 2010-03-24 Interventions: Biological: CINRYZE Other Name: C1 inhibitor [human] |
Completed |
Study Name: Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema (HAE) Subjects Condition: Hereditary Angioedema Date: 2014-03-17 Interventions:
|